HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT
Clinical trials for HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation technique tested to prepare patients for Life-Saving stem cell transplants
Disease control TerminatedThis early-phase study is testing the safety and best dose of a targeted radiation treatment, given with two chemotherapy drugs, to prepare patients for a donor stem cell transplant. The goal is to better wipe out cancer cells in the bone marrow before receiving healthy donor cel…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 04, 2026 07:50 UTC
-
New drug combo aims to keep blood cancer at bay after transplant
Disease control OngoingThis study is testing whether adding the immunotherapy drug elotuzumab to standard maintenance therapy (lenalidomide) helps keep multiple myeloma from returning after a patient's own stem cell transplant. The trial involves 113 patients who have recently undergone transplant for …
Matched conditions: HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC